MetLife Investment Management’s Scansource SCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $464K | Sell |
12,775
-148
| -1% | -$5.66K | ﹤0.01% | 1790 |
|
|
2025
Q4 | $505K | Hold |
12,923
| – | – | ﹤0.01% | 1786 |
|
|
2025
Q3 | $568K | Sell |
12,923
-1,119
| -8% | -$47.6K | ﹤0.01% | 1745 |
|
|
2025
Q2 | $587K | Sell |
14,042
-574
| -4% | -$21.4K | ﹤0.01% | 1599 |
|
|
2025
Q1 | $497K | Sell |
14,616
-340
| -2% | -$13.9K | ﹤0.01% | 1733 |
|
|
2024
Q4 | $710K | Buy |
14,956
+721
| +5% | +$35.3K | ﹤0.01% | 1599 |
|
|
2024
Q3 | $684K | Hold |
14,235
| – | – | ﹤0.01% | 1610 |
|
|
2024
Q2 | $631K | Buy |
14,235
+1,354
| +11% | +$60.6K | ﹤0.01% | 1596 |
|
|
2024
Q1 | $567K | Hold |
12,881
| – | – | ﹤0.01% | 1600 |
|
|
2023
Q4 | $510K | Hold |
12,881
| – | – | ﹤0.01% | 1672 |
|
|
2023
Q3 | $390K | Hold |
12,881
| – | – | ﹤0.01% | 1785 |
|
|
2023
Q2 | $381K | Hold |
12,881
| – | – | ﹤0.01% | 1878 |
|
|
2023
Q1 | $392K | Hold |
12,881
| – | – | ﹤0.01% | 1796 |
|
|
2022
Q4 | $376K | Hold |
12,881
| – | – | ﹤0.01% | 1829 |
|
|
2022
Q3 | $340K | Hold |
12,881
| – | – | ﹤0.01% | 1912 |
|
|
2022
Q2 | $401K | Hold |
12,881
| – | – | ﹤0.01% | 1815 |
|
|
2022
Q1 | $448K | Buy |
12,881
+4,780
| +59% | +$158K | ﹤0.01% | 1843 |
|
|
2021
Q4 | $284K | Hold |
8,101
| – | – | ﹤0.01% | 1834 |
|
|
2021
Q3 | $282K | Hold |
8,101
| – | – | ﹤0.01% | 1859 |
|
|
2021
Q2 | $228K | Hold |
8,101
| – | – | ﹤0.01% | 2079 |
|
|
2021
Q1 | $243K | Sell |
8,101
-4,061
| -33% | -$118K | ﹤0.01% | 1949 |
|
|
2020
Q4 | $321K | Hold |
12,162
| – | – | ﹤0.01% | 1724 |
|
|
2020
Q3 | $241K | Hold |
12,162
| – | – | ﹤0.01% | 1748 |
|
|
2020
Q2 | $293K | Hold |
12,162
| – | – | ﹤0.01% | 1663 |
|
|
2020
Q1 | $260K | Hold |
12,162
| – | – | ﹤0.01% | 1552 |
|
|
2019
Q4 | $449K | Hold |
12,162
| – | – | ﹤0.01% | 1521 |
|
|
2019
Q3 | $372K | Hold |
12,162
| – | – | ﹤0.01% | 1576 |
|
|
2019
Q2 | $396K | Hold |
12,162
| – | – | ﹤0.01% | 1620 |
|
|
2019
Q1 | $436K | Hold |
12,162
| – | – | ﹤0.01% | 1540 |
|
|
2018
Q4 | $418K | Hold |
12,162
| – | – | 0.01% | 1478 |
|
|
2018
Q3 | $485K | Hold |
12,162
| – | – | 0.01% | 1567 |
|
|
2018
Q2 | $490K | Hold |
12,162
| – | – | 0.01% | 1412 |
|
|
2018
Q1 | $432K | Hold |
12,162
| – | – | 0.01% | 1455 |
|
|
2017
Q4 | $435K | Buy |
+12,162
| New | +$475K | ﹤0.01% | 1478 |
|
Other funds holding SCSC
VPM
WA
VCM
MetLife Investment Management's SCSC Position: Q1 2026 in Review
MetLife Investment Management reduced its Scansource (SCSC) stake by 1.1% in Q1 2026, selling an estimated $5.66K and leaving 12,775 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #1790.
MetLife Investment Management first reported a position in SCSC in Q4 2017 and has held it in 34 quarters since. The position peaked at $710K in Q4 2024. 201 funds tracked by Wall St. Rank hold SCSC as of Q1 2026.
- MetLife Investment Management held 12,775 shares of Scansource worth $464K as of Q1 2026.
- MetLife Investment Management sold 148 Scansource shares in Q1 2026, an estimated $5.66K.
- Scansource made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1790 holding.
- MetLife Investment Management first reported a position in Scansource in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Scansource position peaked at $710K in Q4 2024.
- 201 funds tracked by Wall St. Rank held Scansource as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.